CClinicalTrials.gg
WithdrawnNCT03894319Updated Apr 12, 2023

Use of Lumbar Motion Monitor to Predict Response to Radiofrequency Ablation After Medial Branch Diagnostic Blocks

An observational study in Back Pain, sponsored by Ohio State University. Withdrawn at 1 site in United States. Open to participants aged 20 Years to 70 Years. Per ClinicalTrials.gov, last updated 2023-04-12.

Sponsored by Ohio State University · Observational

Why this study was withdrawn
Insufficient staff for measurement assessments
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
0
Ages
20 Years to 70 Years
Sex
All
01

Study summary

The study is being performed to determine if adding an objective measurement of back function can assess the success of a commonly performed back injection procedure-lumbar medial branch blocks. Researchers also hope to compare whether those who have objective improvements after lumbar medial branch blocks will also have more successful lumbar medial branch radiofrequency ablation.

Read the detailed description

The current standard of care to determine the success of lumbar medical branch block(s) (MBB) is highly subjective, even if clinicians were to use validated questionairres. Currently, there are no studies that use a validated objective functional outcome measure to practically and efficiently assess lumbar MBB success prior to radiofrequency ablation (RFA). The addition of a validated objective measure of functional impairment to the current standard of care may help us improve in identifying the patients that will benefit from lumbar RFA. It has the potential to minimize procedures of limited benefit with a significant impact on containing healthcare spending. Additionally, it may further knowledge on how to appropriately select patients without relying on the stringent double block diagnostic technique put forth by the CMS that may exclude patients who could greatly benefit from a lumbar RFA.

As the objective measure the study will use a lumber motion monitor (LMM). The LMM weighs less than 5 pounds and fits on with a shoulder harness and belt. The LMM measures motion in all three directions (forward back, side to side, and twisting) just like the spine. The LMM testing may take up to 30 minutes depending on how many tasks can be performed by the participant and how many practice trials are required. The LMM testing includes bending forward and back to upright as fast as possible; comfortably while maintaining a twist position.

02

Conditions studied

  • Back Pain

Browse trials for

03

In context

Back Pain

2,373 studies on the registry are indexed under Back Pain; 284 are open to participants now.

Browse Back Pain studies →

Lead sponsor

Ohio State University is the lead sponsor of 640 studies on the registry; 144 are open to participants now.

Of its 60 completed or terminated interventional studies of FDA-regulated products, 45 (75%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 70 Years
Sexes eligible
All
Sampling method
Non-probability sample

Study population

Adult patients at the Ohio State Comprehensive Spine Center scheduled to undergo lumbar medial branch blockade and possible subsequent radiofrequency ablation.

Inclusion criteria

  • Male or female, 20 years of age to 70 years of age
  • Capable and willing to consent
  • Participants literate in English language
  • Patients with predominately bilateral axial pain and clinical suspicion of lumbar facet pain.
  • Patients who have completed conservative care: physical therapy (PT)

Exclusion criteria

Exclusion Criteria:

  • History of drug abuse/ dependency
  • History of prior lumbar medial branch block or medial branch radiofrequency ablation
  • Changes to analgesic regimen in the last 30 days
  • Allergy to lidocaine or bupivacaine local anesthetic
  • Illiteracy (English)
  • Presence of a clinically diagnosed major psychiatric condition such as bipolar disorder, uncontrolled major depression, schizophrenia
  • Predominately radicular pain.
  • Patient reported limb pain greater than axial low back pain
  • Previous lumbar spine surgery
  • Any condition that the principle investigator may disqualify the patient
  • Pregnancy
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
0 participants (actual)
Patient registry
No
06

What researchers measure

Primary outcomes

  1. Change in functional performance probability P(n).

    The Lumbar Motion Monitor (LMM) is an objective, validated, reproducible and accurate tool to rapidly assess the degree of impairment with a sensitivity and specificity of 92% and 97%, respectively. This device provides a functional measure of trunk range of motion, flexion velocity, extension velocity, flexion acceleration, extension acceleration and compares recordings to a normative database. The LMM is able to provide an overall impairment score known as a "functional performance probability(P(n)).

    Time frame: collected at time points Day 1; Weeks 2,4, and 6; and Months 3,6, and 9

Secondary outcomes

  1. Change in Numeric Rating Scale for Pain

    Validated as a measure of pain. Widely used and mandated through the Department of Veterans Affairs as a pain assessment tool.Use of the NRS for MBB and RFA success is the current post procedure assessment standard of care and widely used nationally and within the Ohio State Spine Center clinics.

    Time frame: collected at time points Day 1; Weeks 2,4, and 6; and Months 3,6, and 9

  2. PROMIS 29

    The PROMIS® 29 Profile v. 2.0 contains 29 items from 8 domains-Physical Function, Depression, Anxiety, Fatigue, Sleep Disturbance, Ability to Participate in Social Roles and Activities, Pain Interference, and Pain Intensity. These PROMIS® Physical Function measures have been validated for the assessment of back pain.

    Time frame: collected at time points Day 1; Weeks 2,4, and 6; and Months 3,6, and 9

07

Study locations

1 site
  • The Ohio State University Medical Center
    Columbus, Ohio 43210, United States
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 12, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT03894319
Lead sponsor
Ohio State University
Responsible party
JayeshVallabh (Assistant Professor- Physical Medicine & Rehabilitation, Ohio State University) — Principal investigator
First posted
Mar 28, 2019
Start date
Jun 6, 2018
Primary completion
Feb 19, 2021
Completion
Feb 19, 2021
Last update
Apr 12, 2023

Study contacts

Jayesh Vallabh, MD
principal investigator · Ohio State University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion